Resistance mechanisms to cancer chemotherapy


Autoria(s): Redmond, K.M.; Wilson, T.R.; Johnston, Patrick; Longley, Daniel
Data(s)

2008

Resumo

Resistance to chemotherapy ('drug resistance') is a fundamental problem that limits the effectiveness of many chemotherapies currently used to treat cancer. Drug resistance can occur due to a variety of mechanisms, such as increased drug inactivation, drug efflux from cancer cells, enhanced repair of chemotherapy-induced damage, activation of pro-survival pathways and inactivation of cell death pathways. In this article, we review some of the major mechanisms of drug resistance and discuss how new molecularly-targeted therapies are being increasingly used to overcome these resistance mechanisms.

Identificador

http://pure.qub.ac.uk/portal/en/publications/resistance-mechanisms-to-cancer-chemotherapy(c04d0c54-4c98-4baa-8180-b93d2b05de33).html

http://dx.doi.org/10.2741/3070

http://www.scopus.com/inward/record.url?scp=42649124337&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Redmond , K M , Wilson , T R , Johnston , P & Longley , D 2008 , ' Resistance mechanisms to cancer chemotherapy ' Frontiers in Biosciences , vol 13 , no. 13 , pp. 5138-5154 . DOI: 10.2741/3070

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300 #Biochemistry, Genetics and Molecular Biology(all) #/dk/atira/pure/subjectarea/asjc/1300/1303 #Biochemistry #/dk/atira/pure/subjectarea/asjc/1300/1307 #Cell Biology
Tipo

article